| ID Source | ID |
|---|---|
| PubMed CID | 150968 |
| CHEBI ID | 798 |
| SCHEMBL ID | 1331839 |
| MeSH ID | M0111021 |
| Synonym |
|---|
| LMST02020070 |
| CHEBI:798 |
| 2126-37-6 |
| nsc77799 |
| nsc-77799 |
| C05294 , |
| 17beta,19-dihydroxyandrost-4-en-3-one |
| 19-hydroxytestosterone , |
| (8r,9s,10s,13s,14s,17s)-17-hydroxy-10-(hydroxymethyl)-13-methyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
| unii-4gs1h36r0u |
| nsc 77799 |
| androst-4-en-3-one, 17,19-dihydroxy-, (17beta)- |
| 4gs1h36r0u , |
| SCHEMBL1331839 |
| androst-4-en-3-one, 17,19-dihydroxy-, (17.beta.)- |
| 17.beta.,19-dihydroxyandrost-4-ene-3-one |
| androst-4-en-3-one, 17.beta.,19-dihydroxy- |
| 17.beta.,19-dihydroxyandrost-4-en-3-one |
| 4-androstene-17.beta.,19-diol-3-one |
| 17beta, 19-dihydroxyandrost-4-en-3-one |
| 17beta, 19-dihydroxy-4-androsten-3-one |
| 17beta,19-dihydroxy-4-androsten-3-one |
| 4-androsten-17.beta.,19-diol-3-one |
| 17,19-dihydroxyandrost-4-en-3-one # |
| w hydroxy testosterone |
| Q27105361 |
| DTXSID801314363 |
| Role | Description |
|---|---|
| mouse metabolite | Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus). |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Class | Description |
|---|---|
| 19-hydroxy steroid | |
| 3-oxo-Delta(4) steroid | A 3-oxo steroid conjugated to a C=C double bond at the alpha,beta position. |
| 17beta-hydroxy steroid | A 17-hydroxy steroid in which the hydroxy group at position 17 has a beta-configuration. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Pathway | Proteins | Compounds |
|---|---|---|
| estradiol biosynthesis II | 1 | 8 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (18.15) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||